Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


10 Ann Intern Med
1 Biochemistry (Mosc)
1 Cell
28 J Infect
2 J Infect Dis
2 J Virol
10 J Virol Methods
21 Lancet
3 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
2 Pediatrics
3 PLoS Comput Biol
32 PLoS One
2 Proc Natl Acad Sci U S A
6 Vaccine
2 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

  1. LEE BP, Dodge JL, Leventhal A, Terrault NA, et al
    Retail Alcohol and Tobacco Sales During COVID-19.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/M20-7271.

  2. ZIPURSKY JS, Stall NM, Silverstein WK, Huang Q, et al
    Alcohol Sales and Alcohol-Related Emergencies During the COVID-19 Pandemic.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/M20-7466.

  3. BILAL U, Tabb LP, Barber S, Diez Roux AV, et al
    Spatial Inequities in COVID-19 Testing, Positivity, Confirmed Cases, and Mortality in 3 U.S. Cities : An Ecological Study.
    Ann Intern Med. 2021 Mar 30. doi: 10.7326/M20-3936.
    PubMed         Abstract available

  4. LERNER AM, Robinson DA, Yang L, Williams CF, et al
    Toward Understanding COVID-19 Recovery: National Institutes of Health Workshop on Postacute COVID-19.
    Ann Intern Med. 2021 Mar 30. doi: 10.7326/M21-1043.
    PubMed         Abstract available

  5. MCKAY SL, Tobolowsky FA, Moritz ED, Hatfield KM, et al
    Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak.
    Ann Intern Med. 2021 Apr 27. doi: 10.7326/M21-0422.
    PubMed         Abstract available

    In adults and children, a rapid POC antigen test for COVID-19 (LumiraDx) had >/=97% sensitivity and specificity vs. RT-PCR.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/ACPJ202107200.
    PubMed         Abstract available

    The single-dose J&J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at >/=14 d.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/ACPJ202107200.
    PubMed         Abstract available

    In adults and children in the ED with COVID-19 symptoms or a confirmed contact, a rapid POC antigen test had >/=72% sensitivity and >/=99% specificity vs. RT-PCR.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/ACPJ202107200.
    PubMed         Abstract available

    Transmission of SARS-CoV-2.
    Ann Intern Med. 2021;174:1036-1037.

  10. MEYEROWITZ EA, Richterman A, Gandhi RT, Sax PE, et al
    Transmission of SARS-CoV-2.
    Ann Intern Med. 2021;174:1037.

    Biochemistry (Mosc)

  11. KORDYUKOVA LV, Shanko AV
    COVID-19: Myths and Reality.
    Biochemistry (Mosc). 2021;86:800-817.
    PubMed         Abstract available


  12. WILLIAMSON EJ, McDonald HI, Bhaskaran K, Walker AJ, et al
    Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.
    BMJ. 2021;374:n1592.
    PubMed         Abstract available

    No veterinarians (yet) on the Italian covid-19 scientific committee.
    BMJ. 2021;374:n1719.

  14. COURTENAY K, Cooper V
    Covid 19: People with learning disabilities are highly vulnerable.
    BMJ. 2021;374:n1701.

  15. SKEGG DC, Hill PC
    Defining covid-19 elimination.
    BMJ. 2021;374:n1794.

  16. CHIA K
    Alternatives to traditional medical work experience for aspiring medical students.
    BMJ. 2021;374:n1835.

  17. SAXENA S, Skirrow H, Wighton K
    Should the UK vaccinate children and adolescents against covid-19?
    BMJ. 2021;374:n1866.


    Unraveling the long-term effect of influenza vaccines.
    Cell. 2021;184:3845-3847.
    PubMed         Abstract available

    J Infect

  19. FONSECA V, de Jesus R, Adelino T, Reis AB, et al
    Genomic evidence of SARS-CoV-2 reinfection case with the emerging B.1.2 variant in Brazil.
    J Infect. 2021 May 21. pii: S0163-4453(21)00256.

    Mucormycosis - a serious threat in the COVID-19 pandemic?
    J Infect. 2021 May 21. pii: S0163-4453(21)00257.

  21. YAMAMOTO S, Tanaka A, Oshiro Y, Ishii M, et al
    Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.
    J Infect. 2021 May 24. pii: S0163-4453(21)00259.

  22. J BP, Jolly B, John N, Bhoyar RC, et al
    Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India.
    J Infect. 2021 May 24. pii: S0163-4453(21)00260.

  23. VENTURAS J, Zamparini J, Shaddock E, Stacey S, et al
    Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19.
    J Infect. 2021 May 26. pii: S0163-4453(21)00262.
    PubMed         Abstract available

  24. CARAMELLO V, Boccuzzi A, Basile V, Ferraro A, et al
    Are antigenic tests useful for detecting SARS-CoV-2 infections in patients accessing to emergency departments? Results from a North-West Italy Hospital.
    J Infect. 2021 May 20. pii: S0163-4453(21)00255.

  25. ZARIF A, Joy M, Sherlock J, Sheppard JP, et al
    The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study.
    J Infect. 2021 May 15. pii: S0163-4453(21)00220.
    PubMed         Abstract available

  26. HOTHAM M
    Potential future implications of the COVID-19 pandemic on Norovirus infections in England.
    J Infect. 2021 May 13. pii: S0163-4453(21)00241.

  27. MANN JA, Bird PW, Bandi S, Tang JW, et al
    Asymptomatic SARS-CoV-2-infected children attending hospital with non-COVID-19 diagnoses, March 2020-February 2021.
    J Infect. 2021 May 13. pii: S0163-4453(21)00240.

  28. WINCHESTER S, John S, Jabbar K, John I, et al
    Clinical Efficacy of Nitric Oxide Nasal Spray (NONS) for the Treatment of Mild COVID-19 Infection.
    J Infect. 2021 May 13. pii: S0163-4453(21)00251.
    PubMed         Abstract available

  29. WHITAKER HJ, Elgohari S, Rowe C, Otter AD, et al
    Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021.
    J Infect. 2021 May 11. pii: S0163-4453(21)00224.
    PubMed         Abstract available

  30. FERNANDEZ-VILLA T, Vazquez-Casares A, Rivero-Rodriguez A, Carvajal-Urena A, et al
    Rapid antigen test for SARS-CoV-2 and primary health care.
    J Infect. 2021 May 7. pii: S0163-4453(21)00226.

  31. BADDAL B, Bostanci A, Suer K, Sanlidag T, et al
    SARS-CoV-2 was already in circulation in Northern Cyprus in the prepandemic period.
    J Infect. 2021 Mar 1. pii: S0163-4453(21)00097.

  32. PALLOTTO C, Blanc P, Esperti S, Suardi LR, et al
    Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19).
    J Infect. 2021 May 28. pii: S0163-4453(21)00267.

  33. CAPETTI AF, Borgonovo F, Mileto D, Gagliardi G, et al
    One-year durability of anti-spike IgG to SARS-CoV-2: preliminary data from the AntiCROWN prospective observational study One year durability of COVID-19 anti-spike IgG.
    J Infect. 2021 May 27. pii: S0163-4453(21)00264.
    PubMed         Abstract available

  34. MOMBELLI M, Hoschler K, Cavassini M, Pascual M, et al
    Seasonal Trivalent Inactivated Influenza Vaccine with Topical Imiquimod in Immunocompromised Patients: a Randomized Controlled Trial.
    J Infect. 2021 Jul 20. pii: S0163-4453(21)00353.
    PubMed         Abstract available

  35. SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
    Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.
    J Infect. 2021 Jun 29. pii: S0163-4453(21)00321.

  36. BUSKERMOLEN M, Te Paske K, van Beek J, Kortbeek T, et al
    Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: viral reactivation or inflammatory rebound?
    J Infect. 2021 Jun 17. pii: S0163-4453(21)00310.

  37. HOMMA Y, Katsuta T, Oka H, Inoue K, et al
    The incubation period of the SARS-CoV-2 B.1.1.7 variant is shorter than that of other strains.
    J Infect. 2021 Jun 16. pii: S0163-4453(21)00306.

  38. ANDERSEN MP, Ostergaard L, Phelps M, Butt JH, et al
    Risk of Coronavirus Disease 2019 (Covid-19) Contraction and Severe Infection in Home- or Healthcare Professionals.
    J Infect. 2021 Jun 15. pii: S0163-4453(21)00305.

  39. CENDEJAS-BUENO E, Romero-Gomez MP, Escosa L, Jimenez-Rodriguez S, et al
    Lower nasopharyngeal viral loads in pediatric population. The missing piece to understand SARS-CoV-2 infection in children?
    J Infect. 2021 Jun 13. pii: S0163-4453(21)00289.
    PubMed         Abstract available

  40. NOH JY, Song JY, Hyun HJ, Yoon JG, et al
    Risk factors for SARS-CoV-2 transmission in non-household clusters.
    J Infect. 2021 Jun 8. pii: S0163-4453(21)00284.

  41. LORENZO VB, Nascimento-Carvalho C
    Differences between children with severe acute lower respiratory infection with or without SARS-Cov-2 infection.
    J Infect. 2021 Jun 3. pii: S0163-4453(21)00280.
    PubMed         Abstract available

  42. FANTINI J, Yahi N, Azzaz F, Chahinian H, et al
    Structural dynamics of SARS-CoV-2 variants: a health monitoring strategy for anticipating Covid-19 outbreaks.
    J Infect. 2021 Jun 2. pii: S0163-4453(21)00281.
    PubMed         Abstract available

  43. STANG A, Robers J, Schonert B, Jockel KH, et al
    The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population.
    J Infect. 2021 Jun 1. pii: S0163-4453(21)00265.

  44. ZHANG N, Chen X, Jia W, Jin T, et al
    Evidence for lack of transmission by close contact and surface touch in a restaurant outbreak of COVID-19.
    J Infect. 2021 May 29. pii: S0163-4453(21)00273.
    PubMed         Abstract available

  45. BREATHNACH AS, Duncan CJA, Bouzidi KE, Hanrath AT, et al
    Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies.
    J Infect. 2021 May 27. pii: S0163-4453(21)00266.

  46. BUTT AA, Khan T, Yan P, Shaikh OS, et al
    Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination.
    J Infect. 2021 May 28. pii: S0163-4453(21)00263.

    J Infect Dis

  47. HALL MD, Anderson JM, Anderson A, Baker D, et al
    Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.
    J Infect Dis. 2021;224.
    PubMed         Abstract available

  48. EIDEN J, Volckaert B, Rudenko O, Aitchison R, et al
    Single Replication M2SR Influenza Vaccine Induced Immune Responses Associated with Protection Against Human Challenge with Highly Drifted H3N2 Influenza Strain.
    J Infect Dis. 2021 Jul 29. pii: 6330582. doi: 10.1093.
    PubMed         Abstract available

    J Virol

  49. DEL SARTO J, Gerlt V, Friedrich ME, Anhlan D, et al
    Phosphorylation of JIP4 at S730 presents anti-viral properties against influenza A virus infection.
    J Virol. 2021 Jul 28:JVI0067221. doi: 10.1128/JVI.00672.
    PubMed         Abstract available

  50. BESTLE D, Limburg H, Kruhl D, Harbig A, et al
    Hemagglutinins of avian influenza viruses are proteolytically activated by TMPRSS2 in human and murine airway cells.
    J Virol. 2021 Jul 28:JVI0090621. doi: 10.1128/JVI.00906.
    PubMed         Abstract available

    J Virol Methods

  51. LEBLANC JJ, Pettipas J, Di Quinzio M, Hatchette TF, et al
    Reliable detection of SARS-CoV-2 with patient-collected swabs and saline gargles: A three-headed comparison on multiple molecular platforms.
    J Virol Methods. 2021;295:114184.
    PubMed         Abstract available

  52. ANANTHARAJAH A, Helaers R, Defour JP, Olive N, et al
    How to choose the right real-time RT-PCR primer sets for the SARS-CoV-2 genome detection?
    J Virol Methods. 2021;295:114197.
    PubMed         Abstract available

  53. SUN Y, Ding C, Chen Q, Xie J, et al
    Digital PCR assay for the effective detection of COVID-19 patients with SARS-CoV-2 low viral load.
    J Virol Methods. 2021;295:114185.
    PubMed         Abstract available

  54. ORSI A, Pennati BM, Bruzzone B, Ricucci V, et al
    On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic.
    J Virol Methods. 2021;295:114201.
    PubMed         Abstract available

  55. DUNDON WG, Settypalli TBK, Spiegel K, Steinrigl A, et al
    Comparison of eleven in vitro diagnostic assays for the detection of SARS-CoV-2 RNA.
    J Virol Methods. 2021;295:114200.
    PubMed         Abstract available

  56. MALECKI M, Luesebrink J, Wendel AF, Mattner F, et al
    Analysis of external quality assessment samples revealed crucial performance differences between commercial RT-PCR assays for SARS-CoV-2 detection when taking extraction methods and real-time-PCR instruments into account.
    J Virol Methods. 2021;295:114202.
    PubMed         Abstract available

  57. AVETYAN D, Chavushyan A, Ghazaryan H, Melkonyan A, et al
    SARS-CoV-2 detection by extraction-free qRT-PCR for massive and rapid COVID-19 diagnosis during a pandemic in Armenia.
    J Virol Methods. 2021;295:114199.
    PubMed         Abstract available

  58. CAMERO M, Lanave G, Catella C, Lucente MS, et al
    Evaluation of virucidal activity of fabrics using feline coronavirus.
    J Virol Methods. 2021;295:114214.
    PubMed         Abstract available

  59. BROWN JR, O'Sullivan DM, Shah D, Atkinson L, et al
    Comparison of SARS-CoV-2 N gene real-time RT-PCR targets and commercially available mastermixes.
    J Virol Methods. 2021;295:114215.
    PubMed         Abstract available

  60. ULLOA S, Bravo C, Ramirez E, Fasce R, et al
    Inactivation of SARS-CoV-2 isolates from lineages B.1.1.7 (Alpha), P.1 (Gamma) and B.1.110 by heating and UV irradiation.
    J Virol Methods. 2021;295:114216.
    PubMed         Abstract available


  61. ORKIN AM, Gill PJ, Ghersi D, Campbell L, et al
    Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.
    JAMA. 2021 Jun 21. pii: 2781397. doi: 10.1001/jama.2021.9941.
    PubMed         Abstract available

    Another COVID-19 Fallout: Teens' Happy Hour With Parents.
    JAMA. 2021 Jun 30. pii: 2781738. doi: 10.1001/jama.2021.11007.

  63. RUBIN R
    Alcohol-Related Diseases Increased as Some People Drank More During the COVID-19 Pandemic.
    JAMA. 2021 Jun 30. pii: 2781739. doi: 10.1001/jama.2021.10626.

  64. PERSAD G, Emanuel EJ
    Ethical Considerations of Offering Benefits to COVID-19 Vaccine Recipients.
    JAMA. 2021 Jul 1. pii: 2781755. doi: 10.1001/jama.2021.11045.

  65. KAVANAGH MM, Gostin LO, Sunder M
    Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic.
    JAMA. 2021 Jul 1. pii: 2781756. doi: 10.1001/jama.2021.10823.

  66. CARICCHIO R, Abbate A, Gordeev I, Meng J, et al
    Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial.
    JAMA. 2021;326:230-239.
    PubMed         Abstract available


  67. WALL EC, Wu M, Harvey R, Kelly G, et al
    AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
    Lancet. 2021 Jun 28. pii: S0140-6736(21)01462.

    More social discontent than pandemic-related risk perception in Colombia.
    Lancet. 2021;398:211.

    Five priorities for universal COVID-19 vaccination.
    Lancet. 2021 Jun 17. pii: S0140-6736(21)01371.

  70. CHAN EYY, Gobat N, Dubois C, Bedson J, et al
    Bottom-up citizen engagement for health emergency and disaster risk management: directions since COVID-19.
    Lancet. 2021 Jun 4. pii: S0140-6736(21)01233.

  71. MCGEORGE E, James J, Abraham N
    The intergenerational project: creating space for play in health care.
    Lancet. 2021;397:1876-1877.

    Yee-Sin Leo: a leader in Singapore's fight against infectious diseases.
    Lancet. 2021;397:1873.

  73. KHAN MS, Ali SAM, Adelaine A, Karan A, et al
    Rethinking vaccine hesitancy among minority groups.
    Lancet. 2021 Apr 21. pii: S0140-6736(21)00938.

    Genomic sequencing in pandemics.
    Lancet. 2021;397:445.

    SOS Brazil: science under attack.
    Lancet. 2021;397:373-374.

  76. CALISHER CH, Carroll D, Colwell R, Corley RB, et al
    Science, not speculation, is essential to determine how SARS-CoV-2 reached humans.
    Lancet. 2021 Jul 5. pii: S0140-6736(21)01419.

  77. GURDASANI D, Drury J, Greenhalgh T, Griffin S, et al
    Mass infection is not an option: we must do more to protect our young.
    Lancet. 2021 Jul 7. pii: S0140-6736(21)01589.

  78. TANRIOVER MD, Doganay HL, Akova M, Guner HR, et al
    Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
    Lancet. 2021 Jul 8. pii: S0140-6736(21)01429.
    PubMed         Abstract available

  79. HORBY P, Staplin N, Haynes R, Landray M, et al
    Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.
    Lancet. 2021;398:300.

  80. YANG C, Zhao H
    Tocilizumab in COVID-19 therapy: who benefits, and how?
    Lancet. 2021;398:299.

  81. NEUMANN AU, Goekkaya M, Dorgham K, Traidl-Hoffmann C, et al
    Tocilizumab in COVID-19 therapy: who benefits, and how?
    Lancet. 2021;398:299-300.

  82. MARKS L
    Past and present women pioneers in biomedical science.
    Lancet. 2021;398:293-295.

  83. MAKONI M
    Social unrest disrupts South African health care.
    Lancet. 2021;398:287.

  84. DRAKE TM, Riad AM, Fairfield CJ, Egan C, et al
    Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
    Lancet. 2021;398:223-237.
    PubMed         Abstract available

  85. HARGREAVES S, Hayward SE, Noori T, McKee M, et al
    COVID-19: counting migrants in.
    Lancet. 2021;398:211-212.

  86. GU X, Cao B
    In-hospital complications associated with COVID-19.
    Lancet. 2021;398:188-190.

  87. REDJOUL R, Le Bouter A, Beckerich F, Fourati S, et al
    Antibody response after second BNT162b2 dose in allogeneic HSCT recipients.
    Lancet. 2021;398:298-299.

    MMWR Morb Mortal Wkly Rep

  88. LEE JT, Althomsons SP, Wu H, Budnitz DS, et al
    Disparities in COVID-19 Vaccination Coverage Among Health Care Personnel Working in Long-Term Care Facilities, by Job Category, National Healthcare Safety Network - United States, March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1036-1039.
    PubMed         Abstract available

  89. RUBIN D, Eisen M, Collins S, Pennington JW, et al
    SARS-CoV-2 Infection in Public School District Employees Following a District-Wide Vaccination Program - Philadelphia County, Pennsylvania, March 21-April 23, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1040-1043.
    PubMed         Abstract available

  90. CHRISTIE A, Brooks JT, Hicks LA, Sauber-Schatz EK, et al
    Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage.
    MMWR Morb Mortal Wkly Rep. 2021;70:1044-1047.
    PubMed         Abstract available

    N Engl J Med

  91. RUBIN EJ, Baden LR, Armstrong KA, Morrissey S, et al
    Audio Interview: The Impact of Covid-19 on Trainees and Junior Faculty.
    N Engl J Med. 2021;385:e21.

  92. THOMPSON MG, Burgess JL, Naleway AL, Tyner H, et al
    Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Jun 30. doi: 10.1056/NEJMoa2107058.
    PubMed         Abstract available


  93. LERNER C, Albertin C, Casillas A, Duru OK, et al
    Patient Portal Reminders for Pediatric Influenza Vaccinations: A Randomized Clinical Trial.
    Pediatrics. 2021 Jul 28. pii: peds.2020-048413. doi: 10.1542/peds.2020-048413.
    PubMed         Abstract available

  94. WYNN CS, Stephens AB, Stockwell MS
    The Potential Role of Patient Portals to Improve Influenza Vaccination.
    Pediatrics. 2021 Jul 28. pii: peds.2021-049932. doi: 10.1542/peds.2021-049932.

    PLoS Comput Biol

  95. TUPPER P, Colijn C
    COVID-19 in schools: Mitigating classroom clusters in the context of variable transmission.
    PLoS Comput Biol. 2021;17:e1009120.
    PubMed         Abstract available

  96. JANG H, Polgreen PM, Segre AM, Pemmaraju SV, et al
    COVID-19 modeling and non-pharmaceutical interventions in an outpatient dialysis unit.
    PLoS Comput Biol. 2021;17:e1009177.
    PubMed         Abstract available

  97. TURTLE J, Riley P, Ben-Nun M, Riley S, et al
    Accurate influenza forecasts using type-specific incidence data for small geographic units.
    PLoS Comput Biol. 2021;17:e1009230.
    PubMed         Abstract available

    PLoS One

  98. HELLE KB, Sadiku A, Zelleke GM, Ibrahim TB, et al
    Is increased mortality by multiple exposures to COVID-19 an overseen factor when aiming for herd immunity?
    PLoS One. 2021;16:e0253758.
    PubMed         Abstract available

  99. KLUDACZ-ALESSANDRI M, Hawrysz L, Korneta P, Gierszewska G, et al
    The impact of medical teleconsultations on general practitioner-patient communication during COVID- 19: A case study from Poland.
    PLoS One. 2021;16:e0254960.
    PubMed         Abstract available

  100. STODDARD M, Sarkar S, Yuan L, Nolan RP, et al
    Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2.
    PLoS One. 2021;16:e0254734.
    PubMed         Abstract available

  101. JIWA N, Mutneja R, Henry L, Fiscus G, et al
    Development of a brief scoring system to predict any-cause mortality in patients hospitalized with COVID-19 infection.
    PLoS One. 2021;16:e0254580.
    PubMed         Abstract available

  102. YASSI A, Grant JM, Lockhart K, Barker S, et al
    Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data.
    PLoS One. 2021;16:e0254920.
    PubMed         Abstract available

  103. ESKANDARI A, Brojakowska A, Bisserier M, Bander J, et al
    Retrospective analysis of demographic factors in COVID-19 patients entering the Mount Sinai Health System.
    PLoS One. 2021;16:e0254707.
    PubMed         Abstract available

  104. CHOI YJ, Park JY, Lee HS, Suh J, et al
    Variable effects of underlying diseases on the prognosis of patients with COVID-19.
    PLoS One. 2021;16:e0254258.
    PubMed         Abstract available

  105. OKA T, Wei W, Zhu D
    The effect of human mobility restrictions on the COVID-19 transmission network in China.
    PLoS One. 2021;16:e0254403.
    PubMed         Abstract available

  106. ALVAREZ MM, Bravo-Gonzalez S, Trujillo-de Santiago G
    Modeling vaccination strategies in an Excel spreadsheet: Increasing the rate of vaccination is more effective than increasing the vaccination coverage for containing COVID-19.
    PLoS One. 2021;16:e0254430.
    PubMed         Abstract available

  107. HIRSCHBUHL K, Dintner S, Beer M, Wylezich C, et al
    Viral mapping in COVID-19 deceased in the Augsburg autopsy series of the first wave: A multiorgan and multimethodological approach.
    PLoS One. 2021;16:e0254872.
    PubMed         Abstract available

  108. ZIMMERMANN IR, Sanchez MN, Frio GS, Alves LC, et al
    Trends in COVID-19 case-fatality rates in Brazilian public hospitals: A longitudinal cohort of 398,063 hospital admissions from 1st March to 3rd October 2020.
    PLoS One. 2021;16:e0254633.
    PubMed         Abstract available

  109. SAHNI PS, Singh K, Sharma N, Garg R, et al
    Yoga an effective strategy for self-management of stress-related problems and wellbeing during COVID19 lockdown: A cross-sectional study.
    PLoS One. 2021;16:e0245214.
    PubMed         Abstract available

  110. ALLEMAILEM KS, Almatroudi A, Khan AA, Rahmani AH, et al
    Manifestations of renal system involvement in hospitalized patients with COVID-19 in Saudi Arabia.
    PLoS One. 2021;16:e0253036.
    PubMed         Abstract available

  111. LU M, Ishwaran H
    Cure and death play a role in understanding dynamics for COVID-19: Data-driven competing risk compartmental models, with and without vaccination.
    PLoS One. 2021;16:e0254397.
    PubMed         Abstract available

  112. NAM NH, Tien PTM, Truong LV, El-Ramly TA, et al
    Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.
    PLoS One. 2021;16:e0254012.
    PubMed         Abstract available

  113. OTAKI F, Zaher S, Du Plessis S, Lakhtakia R, et al
    Introducing the 4Ps Model of Transitioning to Distance Learning: A convergent mixed methods study conducted during the COVID-19 pandemic.
    PLoS One. 2021;16:e0253662.
    PubMed         Abstract available

  114. SHANMUGAM R, Ledlow G, Singh KP
    Predicting COVID-19 cases with unknown homogeneous or heterogeneous resistance to infectivity.
    PLoS One. 2021;16:e0254313.
    PubMed         Abstract available

  115. NGUYEN HL, Tran OT, Ha DA, Phan VH, et al
    Impact of the COVID-19 pandemic on clinical research activities: Survey of study participants and health care workers participating in a hypertension trial in Vietnam.
    PLoS One. 2021;16:e0253664.
    PubMed         Abstract available

  116. DANIELS LB, Ren J, Kumar K, Bui QM, et al
    Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.
    PLoS One. 2021;16:e0254635.
    PubMed         Abstract available

  117. GIRGIS SA, Hafez HM, Elarab HE, Sherif B, et al
    SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.
    PLoS One. 2021;16:e0254581.
    PubMed         Abstract available

  118. FELEKE BT, Wale MZ, Yirsaw MT
    Knowledge, attitude and preventive practice towards COVID-19 and associated factors among outpatient service visitors at Debre Markos compressive specialized hospital, north-west Ethiopia, 2020.
    PLoS One. 2021;16:e0251708.
    PubMed         Abstract available

  119. SCOTT N, Saul A, Spelman T, Stoove M, et al
    The introduction of a mandatory mask policy was associated with significantly reduced COVID-19 cases in a major metropolitan city.
    PLoS One. 2021;16:e0253510.
    PubMed         Abstract available

  120. SANYAM SD, Sah SK, Chaudhary P, Burton MJ, et al
    Knowledge and awareness-based survey of COVID-19 within the eye care profession in Nepal: Misinformation is hiding the truth.
    PLoS One. 2021;16:e0254761.
    PubMed         Abstract available

  121. DEPELSENAIRE ACI, Witham K, Veitch M, Wells JW, et al
    Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial.
    PLoS One. 2021;16:e0255282.
    PubMed         Abstract available

  122. TARIQ A, Banda JM, Skums P, Dahal S, et al
    Transmission dynamics and forecasts of the COVID-19 pandemic in Mexico, March-December 2020.
    PLoS One. 2021;16:e0254826.
    PubMed         Abstract available

  123. FERVERS P, Kottlors J, Grosse Hokamp N, Bremm J, et al
    Coronary artery calcification on low-dose chest CT is an early predictor of severe progression of COVID-19-A multi-center, multi-vendor study.
    PLoS One. 2021;16:e0255045.
    PubMed         Abstract available

  124. SINGH DR, Sunuwar DR, Shah SK, Sah LK, et al
    Food insecurity during COVID-19 pandemic: A genuine concern for people from disadvantaged community and low-income families in Province 2 of Nepal.
    PLoS One. 2021;16:e0254954.
    PubMed         Abstract available

  125. TRUBNER F, Steigert L, Echterdiek F, Jung N, et al
    Predictors of COVID-19 in an outpatient fever clinic.
    PLoS One. 2021;16:e0254990.
    PubMed         Abstract available

  126. FRIEDMAN EE, Devlin SA, McNulty MC, Ridgway JP, et al
    SARS-CoV-2 percent positivity and risk factors among people with HIV at an urban academic medical center.
    PLoS One. 2021;16:e0254994.
    PubMed         Abstract available

  127. RAMIREZ-ALDANA R, Gomez-Verjan JC, Bello-Chavolla OY, Garcia-Pena C, et al
    Spatial epidemiological study of the distribution, clustering, and risk factors associated with early COVID-19 mortality in Mexico.
    PLoS One. 2021;16:e0254884.
    PubMed         Abstract available

  128. NAVAR AM, Purinton SN, Hou Q, Taylor RJ, et al
    The impact of race and ethnicity on outcomes in 19,584 adults hospitalized with COVID-19.
    PLoS One. 2021;16:e0254809.
    PubMed         Abstract available

  129. RICHTER J, Fanis P, Tryfonos C, Koptides D, et al
    Molecular epidemiology of SARS-CoV-2 in Cyprus.
    PLoS One. 2021;16:e0248792.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  130. MAROT M, Chevalere J, Spatola N
    Depressed mood, a better predictor of social-distancing compliance and candidate for intervention compared to working memory capacity.
    Proc Natl Acad Sci U S A. 2021;118.

  131. XIE W, Zhang W
    Reply to Marot et al.: The struggle to comply with social-distancing is multifaceted, as are the ways of mitigating it.
    Proc Natl Acad Sci U S A. 2021;118.


  132. KESSELS R, Luyten J, Tubeuf S
    Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general.
    Vaccine. 2021 May 26. pii: S0264-410X(21)00664.
    PubMed         Abstract available

  133. INGROLE RSJ, Tao W, Joshi G, Gill HS, et al
    M2e conjugated gold nanoparticle influenza vaccine displays thermal stability at elevated temperatures and confers protection to ferrets.
    Vaccine. 2021 Jul 20. pii: S0264-410X(21)00909.
    PubMed         Abstract available

  134. CHUA H, Kwan MYW, Chan ELY, Wong JSC, et al
    Influenza vaccine effectiveness against influenza-associated hospitalization in children in Hong Kong, 2010-2020.
    Vaccine. 2021 Jul 20. pii: S0264-410X(21)00873.
    PubMed         Abstract available

  135. ARIAS-FERNANDEZ L, San-Roman Montero J, Gil-Prieto R, Walter S, et al
    Burden of pneumonia in patients with viral and bacterial coinfection in Spain during six consecutive influenza seasons, from 2009-10 to 2014-15.
    Vaccine. 2021 Jul 22. pii: S0264-410X(21)00912.
    PubMed         Abstract available

  136. CALLAHAN AG, Coleman-Cowger VH, Schulkin J, Power ML, et al
    Racial disparities in influenza immunization during pregnancy in the United States: A narrative review of the evidence for disparities and potential interventions.
    Vaccine. 2021 Jul 23. pii: S0264-410X(21)00905.
    PubMed         Abstract available

  137. HINES AM, Murphy N, Mullin C, Barillas J, et al
    Henoch-Schonlein purpura presenting post COVID-19 vaccination.
    Vaccine. 2021 Jun 30. pii: S0264-410X(21)00841.


  138. VERMA J, Subbarao N
    Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability.
    Virology. 2021;561:107-116.
    PubMed         Abstract available

  139. PLAAS M, Seppa K, Gaur N, Kasenomm P, et al
    Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia.
    Virology. 2021;561:65-68.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.